Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+106.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+106.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.8x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 111.31% |
| 2024 | 62.57% |
| 2023 | 18.94% |
| 2022 | 12.62% |
| 2021 | -116.41% |
| 2020 | -13.18% |
| 2019 | -138.98% |
| 2018 | -149.97% |
| 2017 | -88.04% |
| 2016 | 41.69% |